Efficacy and Safety Assessment of Intrathoracic Perfusion Chemotherapy Combined with immunological factor Interleukin-2 in the Treatment of Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study
机构：[1]Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.[2]School of Medicine, Macau University of Science and Technology, 999078, Macau, Macao.[3]Department of Earth Sciences, Kunming University of Science and Technology, 650093, Kunming, China.[4]Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.[5]College of Veterinary Medicine, Sichuan Agricultural University, 610000, Chengdu, China.[6]Undergraduate Department, University of Toronto, M2J4A6, Toronto, Canada.[7]Institute of Medical Information/Library, Chinese Academy of Medical Sciences, 100020 Beijing, China.[8]Division of Sports Science & Physical Education, Tsinghua University, Beijing 100084, China.[9]The Third Affiliated Hospital of Shandong First Medical University, Jinan, 250000, Shandong, China.[10]Faculty of Dentistry, University of Debrecen, Debrecen, Hungary.[11]College of Agriculture, Henan University of Science and Technology, 471023, Luoyang, China.[12]Department of Cardiothoracic Surgery, the Affiliated Hospital of Youjiang Medical University for Nationalities, 18 zhongshan 2nd Road, Baise, Guangxi Province, China.
This work was supported by National Natural
Science Foundation of China (No. 42267063), Clinical
Trials from the Affiliated Drum Tower Hospital,
Medical School of Nanjing University (No.2022-LCYJ-PY-32); Project of Modern Hospital
Management and Development Institute, Aid Project
of Nanjing Drum Tower Hospital Health, Education
& Research Foundation (No. NDYG2021049),
Pharmaceutical Society of Jiangsu Province - Hengrui
Hospital Pharmaceutical Foundation Project
(H202154).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|4 区肿瘤学
最新[2023]版：
大类|3 区医学
小类|4 区肿瘤学
第一作者：
第一作者机构：[1]Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.[2]School of Medicine, Macau University of Science and Technology, 999078, Macau, Macao.[3]Department of Earth Sciences, Kunming University of Science and Technology, 650093, Kunming, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.[3]Department of Earth Sciences, Kunming University of Science and Technology, 650093, Kunming, China.[5]College of Veterinary Medicine, Sichuan Agricultural University, 610000, Chengdu, China.[*1]College of Veterinary Medicine, Sichuan Agricultural University, 610000, Chengdu, China. Rizhu Li, Department of Cardiothoracic Surgery, the Affiliated Hospital of Youjiang Medical University for Nationalities, 18 zhongshan 2nd Road, Baise, Guangxi Province, China.[*2]Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
推荐引用方式(GB/T 7714)：
Cao Qiang,Zhu Jinyi,Wu Xinyan,et al.Efficacy and Safety Assessment of Intrathoracic Perfusion Chemotherapy Combined with immunological factor Interleukin-2 in the Treatment of Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study[J].Journal Of Cancer.2024,15(7):2024-2032.doi:10.7150/jca.92624.
APA：
Cao Qiang,Zhu Jinyi,Wu Xinyan,Li Jiapeng,Chen Yuquan...&Han Dan.(2024).Efficacy and Safety Assessment of Intrathoracic Perfusion Chemotherapy Combined with immunological factor Interleukin-2 in the Treatment of Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study.Journal Of Cancer,15,(7)
MLA：
Cao Qiang,et al."Efficacy and Safety Assessment of Intrathoracic Perfusion Chemotherapy Combined with immunological factor Interleukin-2 in the Treatment of Advanced Non-Small Cell Lung Cancer: A Retrospective Cohort Study".Journal Of Cancer 15..7(2024):2024-2032
